#52026M12485EU review of Eurobank’s planned acquisition of Eurolife Life
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
Eurobank plans to acquire full control of Eurolife Life by buying shares, and the European Commission is reviewing the deal under EU merger rules. The case may be handled through the simplified merger review process, which is typically used for transactions that appear unlikely to raise major competition concerns. The deal mainly affects banking, insurance, and financial services markets in Greece, with some relevance for Cyprus, Bulgaria, Luxembourg, and Romania. Competitors, customers, and other interested parties can send comments to the Commission within 10 days of publication, using case reference M.12485.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Eurobank plans to acquire sole control of Eurolife Life through a share purchase.
- The European Commission is carrying out an initial merger review of the transaction.
- Interested third parties have 10 days from publication to submit comments to the Commission.
Obligations
What this law requires
Interested third parties that choose to submit observations on the proposed Eurobank/Eurolife Life concentration must ensure their observations reach the European Commission no later than 10 days after publication of the notice.
Interested third parties submitting observations must specify the case reference “M.12485 – EUROBANK / EUROLIFE LIFE” in their submission to the European Commission.